ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 709,75
0,98%
Dow Jones
43 487,83
0,78%
DAX
20 903,39
1,31%
Brent Oil
80,005
0,00%
Bitcoin
103 587,88
-0,52%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Biolase Inc (BIOL)

  7. Biolase Inc (BIOL) Actualités

BIOL

Biolase (BIOL)

Biolase Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIOL
DateHeureSourceTitreSymboleSociété
28/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
03/06/202423h17Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BIOLBiolase Inc
13/05/202422h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIOLBiolase Inc
08/03/202412h31Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIOLBiolase Inc
23/02/202422h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BIOLBiolase Inc
14/02/202419h10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BIOLBiolase Inc
14/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIOLBiolase Inc
09/02/202414h44Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
29/01/202412h30PR Newswire (US)BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024NASDAQ:BIOLBiolase Inc
24/01/202423h21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BIOLBiolase Inc
08/01/202422h05PR Newswire (US)BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023NASDAQ:BIOLBiolase Inc
03/01/202422h05PR Newswire (US)BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARDNASDAQ:BIOLBiolase Inc
20/12/202320h13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BIOLBiolase Inc
14/12/202322h05PR Newswire (US)BIOLASE RECEIVES TOP WORKPLACES 2023 AWARDNASDAQ:BIOLBiolase Inc
12/12/202322h05PR Newswire (US)BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser TrialNASDAQ:BIOLBiolase Inc
08/12/202315h23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIOLBiolase Inc
06/12/202319h46PR Newswire (US)BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BIOLBiolase Inc
09/11/202322h05PR Newswire (US)BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIESNASDAQ:BIOLBiolase Inc
08/11/202312h30PR Newswire (US)Landmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR® Perio ProtocolNASDAQ:BIOLBiolase Inc
07/11/202322h05PR Newswire (US)BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023NASDAQ:BIOLBiolase Inc
18/10/202314h00PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:BIOLBiolase Inc
18/09/202322h30PR Newswire (US)BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and WarrantsNASDAQ:BIOLBiolase Inc
15/09/202323h27Edgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:BIOLBiolase Inc
14/09/202315h08Edgar (US Regulatory)Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]NASDAQ:BIOLBiolase Inc
14/09/202305h16PR Newswire (US)BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and WarrantsNASDAQ:BIOLBiolase Inc
14/09/202303h25Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:BIOLBiolase Inc
10/08/202322h05PR Newswire (US)BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEARNASDAQ:BIOLBiolase Inc
02/08/202322h05PR Newswire (US)BIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10, 2023NASDAQ:BIOLBiolase Inc
26/07/202322h30PR Newswire (US)BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLITNASDAQ:BIOLBiolase Inc
17/07/202312h30PR Newswire (US)BIOLASE EPIC HYGIENE DENTAL LASER RECEIVES PRESTIGIOUS CELLERANT BEST OF CLASS HYGIENE AWARDNASDAQ:BIOLBiolase Inc
 Showing the most relevant articles for your search:NASDAQ:BIOL

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
GLE
Societe Generale
COIN
BTCUSD
Bitcoin
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
RNO
Renault
EU
BEL20
Bel 20
COIN
DOGEUSD
Dogecoin
EU
PX1
CAC 40
COIN
ADAUSD
Cardano
EU
RI
Pernod Ricard
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
KO
Coca Cola
FTSE
UKX
FTSE 100
SPI
SP500
S&P 500
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés